| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/13/2007 | EP1794134A1 Substituted 2-anilinopyrimidines as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors, production of said substances and use of the latter as medicaments |
| 06/13/2007 | EP1794133A2 Aryl spirolactam cgrp receptor antagonists |
| 06/13/2007 | EP1793828A2 Fibrate compounds having ppar agonist activity |
| 06/13/2007 | EP1577286B1 Perfluoroallyloxy compound and liquid-crystal composition containing the compound |
| 06/13/2007 | CN1980932A Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the sam |
| 06/13/2007 | CN1980909A Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/13/2007 | CN1980899A Quinazolinone derivatives as parp inhibitors |
| 06/13/2007 | CN1980898A Nucleoside derivatives and therapeutic uses therof |
| 06/13/2007 | CN1980897A 4-phenyl-pyrimidine-2-carbonitrile derivatives |
| 06/13/2007 | CN1980894A Compounds and compositions as PPAR modulators. |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230139 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 06/12/2007 | US7230104 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 06/12/2007 | US7230003 Aromatic prodrugs of propofol, compositions and uses thereof |
| 06/12/2007 | US7230002 Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof |
| 06/12/2007 | US7230000 Administerig quinazolinone amide derivative for therapy of solid tumor |
| 06/12/2007 | US7229995 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | CA2417264C Crystalline therapeutic agent |
| 06/12/2007 | CA2366624C 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 06/07/2007 | WO2007064619A1 Pyrimidine derivatives as hiv integrase inhibitors |
| 06/07/2007 | WO2007064316A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 06/07/2007 | WO2007063935A1 Aromatic compound |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063391A2 Spirocyclic quinazoline derivatives as pde7 inhibitors |
| 06/07/2007 | WO2007063293A1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 06/07/2007 | WO2007063291A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors |
| 06/07/2007 | WO2007062677A1 Thiazolyl- and pyrimidinyl-acetic acids and their use as crth2 receptor ligands |
| 06/07/2007 | WO2006081331A3 Quinoxaline derivatives as antitumor agents |
| 06/07/2007 | WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129380 2-Substituted pyrimidines |
| 06/07/2007 | US20070129356 Mitotic kinesin inhibitors |
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | CA2628817A1 Iminopropene compound and use thereof |
| 06/06/2007 | EP1792898A1 Molecular chaperone function regulator |
| 06/06/2007 | EP1791807A1 Therapeutic diphenyl ether ligands |
| 06/06/2007 | EP1791544A2 Quinazoline derivatives as metabolically inert antifolate compounds |
| 06/06/2007 | CN1976918A 4,5-disubstituted-2-aryl pyrimidines |
| 06/06/2007 | CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor |
| 06/06/2007 | CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 06/06/2007 | CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 06/06/2007 | CN1319974C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 06/06/2007 | CN1319969C Fungicides |
| 06/06/2007 | CN1319950C 3-substituted-4-pyrimidone derivatives |
| 06/06/2007 | CN1319949C Chrysanthemacyl thiourea pyrimidine derivative with bioactivity, and its preparing method and pesticide composition |
| 06/05/2007 | US7227021 Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| 06/05/2007 | US7226927 Administering 2-aryl-4- arylaminopyrimidine and analogs thereof, for therapy of disorder responsive to the induction of apoptosis in an animal suffering therefrom |
| 06/05/2007 | CA2269561C Naphthalene derivative and liquid crystal composition comprising the same |
| 05/31/2007 | WO2007061094A1 Pharmaceutical comprising ppar agonist |
| 05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | WO2007060484A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | WO2007060110A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | WO2007060026A1 Urea derivatives useful as calcium receptor modulators |
| 05/31/2007 | WO2007022964A3 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/31/2007 | WO2007022366A3 Rosuvastatin calcium with a low salt by-product content |
| 05/31/2007 | WO2006091770A3 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
| 05/31/2007 | WO2006004937A3 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 05/31/2007 | WO2005099688A3 Cyclic compounds |
| 05/31/2007 | US20070123550 t-butyl ester of (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methane-sulfonylaminopyrimidin)-5-yl)-3(R)hydroxy-5-oxo-(E)-6-heptenoic acid; crystalline forms may be easier to handle and process than oil intermediates; crystallization in methanol/H2O; heating, cooling, seeding, cooling, recovering |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123548 Pth agonists |
| 05/31/2007 | US20070123537 Quinazoline derivatives for the treatment of herpesviral infections |
| 05/31/2007 | US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |
| 05/31/2007 | US20070123510 Guanidine derivatives |
| 05/31/2007 | US20070123509 Carboxamide derivatives |
| 05/31/2007 | CA2630860A1 Urea derivatives useful as calcium receptor modulators |
| 05/31/2007 | CA2630816A1 Pharmaceutical comprising ppar agonist |
| 05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | CA2630039A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | CA2629554A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/30/2007 | EP1789413A1 Vanilloid receptor ligands and their use in treatments |
| 05/30/2007 | EP1789400A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789398A1 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace) |
| 05/30/2007 | EP1789397A2 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators |
| 05/30/2007 | EP1789014A1 Substance for dyeing keratinic fibers |
| 05/30/2007 | EP1343907B1 Method for the continuous biotechnological production of compatible solutes from toxic substrates |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | CN1972941A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists |
| 05/30/2007 | CN1972918A 嘧啶衍生物 Pyrimidine derivatives |
| 05/30/2007 | CN1972688A 4-phenylamino-quinazolin-6-yl-amides |
| 05/30/2007 | CN1318423C 7-amino triazolopyrimidines for controlling harmful fungi |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
| 05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
| 05/29/2007 | US7223861 Reacting the hydroxyl group of a pryazole derivative with activating agent in the presence of a base, coupling with amine compound, treating with trialkyl orthoformate in the presence of a catalytic amount of an acid, condensing with a hydrazide compound, hydrolysis, cyclization |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223769 4-(alkynyloxy)-6-(alkoxy or cycloalkoxy)pyrimidine compounds |
| 05/29/2007 | US7223768 Fused ring heterocycles as potassium channel modulators |
| 05/29/2007 | US7223767 Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
| 05/29/2007 | US7223766 Bi-cyclic pyrimidine inhibitors of TGFβ |
| 05/29/2007 | US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example |
| 05/29/2007 | US7223756 Treatment of autoimmune diseases, transplant rejection and rheumatoid arthritis with a quinazoline 4-substituted by a methylenedioxyphenyl group linked to the ring by an ether, methyl, sulfide, sulfoxide or sulfone, e.g., 6-methoxy-4-(2,3-methylenedioxyphenoxy)-7-(3-pyrrolidin-1-ylpropoxy)quinazoline, |
| 05/24/2007 | WO2007059229A1 Hiv integrase inhibitors |
| 05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | WO2007058582A1 Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |